The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Current Consensus Guidelines for Treatment of Neurocysticercosis
Open accessAbstract
SUMMARY: Taenia solium neurocysticercosis is a common cause of epileptic seizures and other neurological morbidity in most developing countries. It is also an increasingly common diagnosis in industrialized countries because of immigration from areas where it is endemic. Its clinical manifestations are highly variable and depend on the number, stage, and size of the lesions and the host's immune response. In part due to this variability, major discrepancies exist in the treatment of neurocysticercosis. A panel of experts in taeniasis/cysticercosis discussed the evidence on treatment of neurocysticercosis for each clinical presentation, and we present the panel's consensus and areas of disagreement. Overall, four general recommendations were made: (i) individualize therapeutic decisions, including whether to use antiparasitic drugs, based on the number, location, and viability of the parasites within the nervous system; (ii) actively manage growing cysticerci either with antiparasitic drugs or surgical excision; (iii) prioritize the management of intracranial hypertension secondary to neurocysticercosis before considering any other form of therapy; and (iv) manage seizures as done for seizures due to other causes of secondary seizures (remote symptomatic seizures) because they are due to an organic focus that has been present for a long time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kennedy, C. O. (1971) · British Homeopathic Journal · doi:10.1016/s0007-0785(71)80027-3 · Cited by 974
Del Brutto, O. H., & Sotelo, J. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.6.1075 · Cited by 334
Self-citationCysticercosis and Epilepsy: A Critical Review
Carpio, A., Escobar, A., & Hauser, W. A. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01287.x · Cited by 289
Garcia, H. H., & Del Brutto, O. H. (2000) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70220-8 · Cited by 259
Self-citationCysticercosis: an analysis and follow-up of 450 cases.
Dixon, H. B. F., & Lipscomb, F. M. (1961) · Biblioteca Digital (Real Academia Nacional de Medicina) · Cited by 249
Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis
Del Brutto, O. H., Wadia, N. H., Dumas, M., Cruz, M., Tsang, V. C. W., & Schantz, P. M. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00130-x · Cited by 235
Self-citationComparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis
Sotelo, J., del Brutto, O. H., Penagos, P., Escobedo, F., Torres, B., Rodriguez-Carbajal, J., & Rubio-Donnadieu, F. (1990) · Journal of Neurology · doi:10.1007/bf00314663 · Cited by 214
Self-citationCYSTICERCOSIS CAUSING SINGLE, SMALL CT LESIONS IN INDIAN PATIENTS WITH SEIZURES
Chandy, M., Rajshekhar, V., Prakash, S., Ghosh, S., Joseph, T., Abraham, J., & Chandi, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91771-6 · Cited by 202
Self-citationTherapy for Neurocysticercosis: Comparison Between Albendazole and Praziquantel
Takayanagui, O. M. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530270106026 · Cited by 190
Self-citationAlbendazole Therapy for Neurocysticercosis
Escobedo, F. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370040120021 · Cited by 170
Is the Course of Neurocysticercosis Modified by Treatment With Antihelminthic Agents?
Carpio, A., Santillán, F., León, P., Flores, C., & Hauser, W. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430180088010 · Cited by 169
Albendazole vs Praziquantel for Therapy for Neurocysticercosis: A Controlled Trial
Sotelo, J., Escobedo, F., & Penagos, P. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520290064015 · Cited by 161
Brain surgery : complication avoidance and management
Apuzzo, M. L. J. (1993) · Churchill Livingstone eBooks · Cited by 155
Plasma levels of praziquantel decrease when dexamethasone is given simultaneously
Vázquez, M. L., Jung, H., & Sotelo, J. (1987) · Neurology · doi:10.1212/wnl.37.9.1561 · Cited by 146
Schantz, P. M., Wilkins, P. P., & Tsang, V. C. W. (2014) · ASM Press eBooks · doi:10.1128/9781555816957.ch12 · Cited by 145
Self-citationDexamethasone increases plasma levels of albendazole
Jung, H., Hurtado, M., Medina, M. T., Sánchez, M., & Sotelo, J. (1990) · Journal of Neurology · doi:10.1007/bf00314741 · Cited by 125
Neurocysticercosis: Focus on Intraventricular Disease
Cuetter, A. C., Garcia-Bobadilla, J., Guerra, L. G., Martinez, F. M., & Kaim, B. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.157 · Cited by 120
Therapy for Neurocysticercosis: A Reappraisal
Brutto, Ó. H. D., Sotelo, J., & Román, G. C. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.730 · Cited by 120
Extraparenchymal Neurocysticercosis: Report of Five Cases and Review of Management
Bandrés, J. C., White, A. C., Samo, T., Murphy, E. C., & Harris, R. L. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.5.799 · Cited by 114
Self-citationEndoscopic management of cysticercal cysts within the lateral and third ventricles
Bergsneider, M., Holly, L. T., Lee, J. H., King, W. A., & Frazee, J. G. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.92.1.0014 · Cited by 112
(1998) · ASM Press eBooks · doi:10.1128/9781555816957 · Cited by 108
Albendazole therapy for neurocysticercosis
Garcia, H. H., Gilman, R. H., Horton, J. D., Martinez, M., Herrera, G., Altamirano, J., Cuba, J. M., Rios-Saavedra, N., Verástegui, M., Boero, J., et al. (1997) · Neurology · doi:10.1212/wnl.48.5.1421 · Cited by 107
Self-citationParenchymal neurocysticercosis: follow-up and staging by MRI
Dumas, J. L., Visy, J.-M., Belin, C., Goldlust, D., Dumas, M., & Gaston, A. (1997) · Neuroradiology · doi:10.1007/s002340050358 · Cited by 103
Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle
Proaño, J. V., Madrazo, I., García, L., García-Torres, E., & Correa, D. (1997) · Journal of neurosurgery · doi:10.3171/jns.1997.87.1.0029 · Cited by 90
Self-citationMedical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases
Martínez, H. R., Rangel‐Guerra, R., Arredondo-Estrada, J. H., Marfil-Rivera, A., & Pinedo-Onofre, J. A. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00278-v · Cited by 88
Albendazole Therapy for Giant Subarachnoid Cysticerci
Brutto, Ó. H. D., Sotelo, J., Aguirre, R., Diaz-Calderon, E., & Alarcón, T. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290123021 · Cited by 86
Plasma and CSF Levels of Albendazole and Praziquantel in Patients with Neurocysticercosis
Jung, H., Hurtado, M., Sánchez, M., Medina, M. T., & Sotelo, J. (1990) · Clinical Neuropharmacology · doi:10.1097/00002826-199012000-00008 · Cited by 82
Cerebral Cysticercosis Treated Biphasically with Dexamethasone and Praziquantel
deGHETALDI, L. D., NORMAN, R. M., & DOUVILLE, A. W. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-2-179 · Cited by 79
Medical Treatment of Cysticercosis--Ineffective
Kramer, L. D. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540250109020 · Cited by 77
Takayanagui, O. M., Lanchote, V. L., Marques, M. P., & Bonato, P. S. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199702000-00009 · Cited by 76
Self-citationEndoscopic removal of cysticercal cysts within the fourth ventricle
Bergsneider, M. (1999) · Journal of neurosurgery · doi:10.3171/jns.1999.91.2.0340 · Cited by 75
Spontaneous radiographic disappearance of cerebral cysticercosis: Three cases
Miller, B. L., Grinnell, V. S., Goldberg, M. A., & Heiner, D. C. (1983) · Neurology · doi:10.1212/wnl.33.10.1377 · Cited by 71
Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients.
Brutto, Ó. H. D. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.6.659 · Cited by 69
Suástegui, R., Soto‐Hernández, J. L., & Sotelo, J. (1996) · Journal of neurosurgery · doi:10.3171/jns.1996.84.4.0629 · Cited by 67
Single-day praziquantel versus 1-week albendazole for neurocysticercosis
Brutto, Ó. H. D., Campos, X., Sánchez, J., & Mosquera, A. (1999) · Neurology · doi:10.1212/wnl.52.5.1079 · Cited by 65
Neurocysticercosis: Short Course of Treatment With Albendazole
Alarcón, F. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520470099034 · Cited by 63 · cited 1×
“The initial length of therapy was 1 month, later reduced to 15 days and 1 week (2, 3, 14, 21, 29, 55, 63, 89, 90, 94, 95, 98, 111).”
Albendazole in neurocysticercosis.
Padma, M. V., Behari, M., Misra, N. K., & Gk, A. (1995) · PubMed · Cited by 57
Die tierischen Parasiten des Zentralnervensystems
Henneberg, R. (1936) · Springer eBooks · doi:10.1007/978-3-642-99698-6_4 · Cited by 53
Neurocysticercosis: optimal dose treatment with albendazole
Cruz, I., Cruz, M. E., Carrasco, F. C., & Horton, J. D. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00181-z · Cited by 49
Severe forms of neurocysticercosis: treatment with albendazole
Agapejev, S., da Silva, M. D., & Ueda, A. K. (1996) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x1996000100014 · Cited by 37
Short course albendazole treatment for neurocysticercosis in Columbia
Botero, D., Uribe, C. S., Sanchez, J. L., Yepes, T. A., Velásquez, G., Ocampo, N. E., & Villa, L. A. (1993) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(93)90095-8 · Cited by 35
Self-citationOutcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea
Kim, S., Wang, K., Paek, S.-H., Hong, K., & Cho, B.-K. (1999) · Surgical Neurology · doi:10.1016/s0090-3019(99)00158-5 · Cited by 28
Antihelminthic Therapy for Neurocysticercosis
Kramer, L. D. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530100019004 · Cited by 17
Albendazole Therapy for Giant Subarachnoid Cysticerci
Noboa, C. A. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540040009006 · Cited by 15
Albendazole therapy for neurocysticercosis.
Sanchetee, P., Venkataraman, S., Rm, D., & Roy, A. K. (1994) · PubMed · Cited by 9
Treatment of neurocysticercosis with a two week course of albendazole.
Chotmongkol, V. (1993) · PubMed · Cited by 3
Cited by
García, H. H., Gonzalez, A. E., Evans, C. A., & Gilman, R. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14117-7 · Cited by 835
Self-citationClinical symptoms, diagnosis, and treatment of neurocysticercosis
Garcia, H. H., Nash, T. E., & Del Brutto, O. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70094-8 · Cited by 594
Self-citationNeurocysticercosis: updated concepts about an old disease
Garcia, H. H., & Del Brutto, O. H. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70194-0 · Cited by 554
Self-citationA Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis
Garcia, H. H., Pretell, E. J., Gilman, R. H., Martinez, S. M., Moulton, L. H., Del Brutto, O. H., Herrera, G., Evans, C. A. W., & Gonzalez, A. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031294 · Cited by 418
Self-citationAlbendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
Chai, J.-Y., Jung, B.-K., & Hong, S.-J. (2021) · The Korean Journal of Parasitology · doi:10.3347/kjp.2021.59.3.189 · Cited by 286
Metadata
- Authors
- García, H. H., Evans, C. A. W., Nash, T. E., Takayanagui, O. M., White, A. C., Botero, D., Rajshekhar, V., Tsang, V. C. W., Schantz, P. M., Allan, J. C., Flisser, A., Correa, D., Sarti, E., Friedland, J. S., Martinez, S. M., Gonzalez, A. E., Gilman, R. H., & Del Brutto, O. H.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2002-10
- Volume
- 15
- Issue
- 4
- Pages
- 747-756
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2150840647
- Cited by
- 508
- References
- 46
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.